Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Detecting Fractional Chern Insulators through Circular Dichroism.

Repellin C, Goldman N.

Phys Rev Lett. 2019 Apr 26;122(16):166801. doi: 10.1103/PhysRevLett.122.166801.

PMID:
31075039
2.

Modular Antigen-Specific T-cell Biofactories for Calibrated In Vivo Synthesis of Engineered Proteins.

Repellin CE, Patel P, Beviglia L, Javitz H, Sambucetti L, Bhatnagar P.

Adv Biosyst. 2018 Dec;2(12). pii: 1800210. doi: 10.1002/adbi.201800210. Epub 2018 Sep 14.

PMID:
30984819
3.

Lattices for fractional Chern insulators.

Repellin C, Regnault N.

Science. 2018 Apr 6;360(6384):31-32. doi: 10.1126/science.aar5675. No abstract available.

PMID:
29622642
4.

Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis.

Wilkes MC, Repellin CE, Sakamoto KM.

Mol Genet Metab. 2017 Nov;122(3):28-38. doi: 10.1016/j.ymgme.2017.07.008. Epub 2017 Jul 25. Review.

5.

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.

Kosaka T, Tanizaki J, Paranal RM, Endoh H, Lydon C, Capelletti M, Repellin CE, Choi J, Ogino A, Calles A, Ercan D, Redig AJ, Bahcall M, Oxnard GR, Eck MJ, Jänne PA.

Cancer Res. 2017 May 15;77(10):2712-2721. doi: 10.1158/0008-5472.CAN-16-3404. Epub 2017 Mar 31.

6.

Sorting nexin 9 differentiates ligand-activated Smad3 from Smad2 for nuclear import and transforming growth factor β signaling.

Wilkes MC, Repellin CE, Kang JH, Andrianifahanana M, Yin X, Leof EB.

Mol Biol Cell. 2015 Nov 1;26(21):3879-91. doi: 10.1091/mbc.E15-07-0545. Epub 2015 Sep 2.

7.

Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases.

Andrianifahanana M, Wilkes MC, Gupta SK, Rahimi RA, Repellin CE, Edens M, Wittenberger J, Yin X, Maidl E, Becker J, Leof EB.

FASEB J. 2013 Nov;27(11):4444-54. doi: 10.1096/fj.12-224907. Epub 2013 Aug 2.

8.

Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathway.

Cortot AB, Repellin CE, Shimamura T, Capelletti M, Zejnullahu K, Ercan D, Christensen JG, Wong KK, Gray NS, Jänne PA.

Cancer Res. 2013 Jan 15;73(2):834-43. doi: 10.1158/0008-5472.CAN-12-2066. Epub 2012 Nov 19.

9.

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

Ercan D, Xu C, Yanagita M, Monast CS, Pratilas CA, Montero J, Butaney M, Shimamura T, Sholl L, Ivanova EV, Tadi M, Rogers A, Repellin C, Capelletti M, Maertens O, Goetz EM, Letai A, Garraway LA, Lazzara MJ, Rosen N, Gray NS, Wong KK, Jänne PA.

Cancer Discov. 2012 Oct;2(10):934-47. doi: 10.1158/2159-8290.CD-12-0103. Epub 2012 Sep 7.

10.

Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2.

Penheiter SG, Singh RD, Repellin CE, Wilkes MC, Edens M, Howe PH, Pagano RE, Leof EB.

Mol Biol Cell. 2010 Nov 15;21(22):4009-19. doi: 10.1091/mbc.E09-12-1019. Epub 2010 Sep 29.

11.

ERBB receptor activation is required for profibrotic responses to transforming growth factor beta.

Andrianifahanana M, Wilkes MC, Repellin CE, Edens M, Kottom TJ, Rahimi RA, Leof EB.

Cancer Res. 2010 Oct 1;70(19):7421-30. doi: 10.1158/0008-5472.CAN-10-0232. Epub 2010 Sep 14.

12.

Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus.

Repellin CE, Tsimbouri PM, Philbey AW, Wilson JB.

PLoS One. 2010 Feb 8;5(2):e9092. doi: 10.1371/journal.pone.0009092.

13.

Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Wilkes MC, Repellin CE, Hong M, Bracamonte M, Penheiter SG, Borg JP, Leof EB.

Dev Cell. 2009 Mar;16(3):433-44. doi: 10.1016/j.devcel.2009.01.009.

14.

Protease inhibitors prevent the protein kinase A-dependent loss of Rap1 GTPase from the particulate fraction of COS1 cells.

Rundell CJ, Repellin CE, Yarwood SJ.

Biochem Biophys Res Commun. 2004 Mar 19;315(4):1077-81.

PMID:
14985123
15.

The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element.

Cumming SA, Repellin CE, McPhillips M, Radford JC, Clements JB, Graham SV.

J Virol. 2002 Jun;76(12):5993-6003.

16.

Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.

Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T.

Oncogene. 2002 Mar 14;21(12):1876-81.

17.

Analysis of CHK2 in vulval neoplasia.

Reddy A, Yuille M, Sullivan A, Repellin C, Bell A, Tidy JA, Evans DJ, Farrell PJ, Gusterson B, Gasco M, Crook T.

Br J Cancer. 2002 Mar 4;86(5):756-60.

18.

Concomitant inactivation of p53 and Chk2 in breast cancer.

Sullivan A, Yuille M, Repellin C, Reddy A, Reelfs O, Bell A, Dunne B, Gusterson BA, Osin P, Farrell PJ, Yulug I, Evans A, Ozcelik T, Gasco M, Crook T.

Oncogene. 2002 Feb 21;21(9):1316-24.

Supplemental Content

Loading ...
Support Center